IRIS UniCatt

Mirabella, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.061
NA - Nord America 5.586
AS - Asia 2.345
SA - Sud America 532
AF - Africa 77
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 11
Totale 14.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.525
DE - Germania 2.266
SE - Svezia 1.182
SG - Singapore 871
CN - Cina 835
IT - Italia 557
BR - Brasile 480
UA - Ucraina 441
IE - Irlanda 328
FR - Francia 282
FI - Finlandia 271
ID - Indonesia 206
GB - Regno Unito 193
PL - Polonia 169
IN - India 141
RU - Federazione Russa 132
TR - Turchia 52
KR - Corea 49
CI - Costa d'Avorio 48
BE - Belgio 41
NL - Olanda 39
AT - Austria 36
CA - Canada 35
VN - Vietnam 35
IR - Iran 30
JP - Giappone 28
HK - Hong Kong 26
ES - Italia 17
AU - Australia 14
CZ - Repubblica Ceca 14
AR - Argentina 13
CH - Svizzera 12
IQ - Iraq 12
RO - Romania 12
EC - Ecuador 11
ZA - Sudafrica 11
CL - Cile 10
PT - Portogallo 9
A2 - ???statistics.table.value.countryCode.A2??? 8
MX - Messico 8
CO - Colombia 7
HU - Ungheria 7
DK - Danimarca 6
MA - Marocco 6
PA - Panama 6
AE - Emirati Arabi Uniti 5
AM - Armenia 5
EE - Estonia 5
LT - Lituania 5
LV - Lettonia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
SK - Slovacchia (Repubblica Slovacca) 5
BD - Bangladesh 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
IL - Israele 4
KZ - Kazakistan 4
MD - Moldavia 4
TH - Thailandia 4
AZ - Azerbaigian 3
BO - Bolivia 3
CU - Cuba 3
DZ - Algeria 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
PH - Filippine 3
TN - Tunisia 3
VE - Venezuela 3
AL - Albania 2
BN - Brunei Darussalam 2
CY - Cipro 2
EG - Egitto 2
EU - Europa 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AO - Angola 1
BH - Bahrain 1
GE - Georgia 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LI - Liechtenstein 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
Totale 14.628
Salva come PNG Salva come JPEG
Città #
Chandler 1.168
Singapore 508
Ashburn 449
Munich 333
Dublin 323
Jacksonville 292
San Mateo 266
Jakarta 206
Wilmington 171
New York 163
Ann Arbor 161
Nanjing 156
Warsaw 155
Helsinki 151
Nürnberg 150
Boston 126
Houston 106
Redmond 104
Princeton 97
Woodbridge 97
Dearborn 95
Moscow 87
Rome 83
Beijing 82
Los Angeles 80
Milan 75
Lawrence 72
Chicago 70
Cattolica 66
Fairfield 64
Nanchang 63
Redwood City 60
Seattle 60
Marseille 54
Hefei 53
Bremen 52
Abidjan 48
São Paulo 47
Norwalk 45
Seoul 45
Nuremberg 39
Brussels 37
Hebei 35
Izmir 35
Detroit 31
Mountain View 30
North Bergen 29
University Park 29
Düsseldorf 27
Guangzhou 26
Kunming 26
Pune 26
Leawood 25
Boardman 24
Frankfurt am Main 24
Shenyang 23
Tianjin 22
Shanghai 21
Vienna 21
Hong Kong 20
Jiaxing 20
Changsha 19
Hangzhou 19
London 17
Portsmouth 17
Belo Horizonte 16
Falls Church 16
Fremont 16
Salt Lake City 16
Florence 15
Washington 14
Lauterbourg 13
The Dalles 13
Toronto 13
Brooklyn 12
Jyväskylä 12
Phoenix 12
Rio de Janeiro 12
Zhengzhou 12
Buffalo 11
Cambridge 11
Hanoi 11
Falkenstein 10
Hyderabad 10
Atlanta 9
Lancaster 9
Lappeenranta 9
Simi Valley 9
Andover 8
Auburn Hills 8
Caxias do Sul 8
Changchun 8
Edinburgh 8
Jinan 8
Paris 8
Philadelphia 8
Porto Alegre 8
Tokyo 8
Bari 7
Busto Arsizio 7
Totale 7.500
Salva come PNG Salva come JPEG
Nome #
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. 327
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 269
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 218
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 209
Upper body involvement in GNE myopathy assessed by muscle imaging 204
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 202
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments 173
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 171
Hospital admissions from the emergency department of adult patients affected by myopathies 169
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 169
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 156
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 154
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 149
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 148
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 145
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 145
Muscle imaging findings in GNE myopathy 137
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 136
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 132
A Case of Hemiabdominal Myoclonus 131
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 127
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 125
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. 122
A human anti-Neuronal Autoantibody Against GABAB Receptor induces Experimental Autoimmune Agrypnia 121
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene 119
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 117
Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis 115
Muscle MRI in female carriers of dystrophinopathy 115
Acyclovir-related kidney injury during alemtuzumab infusion 115
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 114
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle 110
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 108
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 108
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 107
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 106
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles 103
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 102
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 101
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 100
Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy 99
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 98
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 98
Coeliac disease presenting with acute disseminated encephalomyelitis 96
TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis 96
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy 96
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 96
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. 92
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 92
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 89
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 88
Case of postpartum Parsonage-Turner syndrome 87
ANCA-related vasculitic neuropathy mimicking motor neuron disease. 86
A Case of Hemiabdominal Myoclonus 85
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 84
Bilateral thoracic long nerve involvement in motor multifocal neuropathy 84
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 84
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 83
A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis 83
An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation 82
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 82
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 82
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 81
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 81
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 81
Coeliac disease presenting with acute disseminated encephalomyelitis. 80
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 80
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 80
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 80
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 79
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 77
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 75
Increased aging in primary muscle cultures of sporadic inclusion-body myositis. 75
Fingolimod vs dimethyl fumarate in multiple sclerosis 75
Relapsing-remitting autoimmune agrypnia 74
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 74
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 73
Clinical characteristics, course and prognosis of spinal multiple sclerosis 73
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 73
Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration 72
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 72
Hereditary inclusion-body myopathies 71
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 71
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 71
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 70
Rasmussen encephalitis: an unusual cause for intractable seizures in elderly 69
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 69
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 69
Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy 68
Chapter 28- Hereditary Inclusion-Body Myopathies 68
A unique case of multiphasic ADEM or what else? 68
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis 67
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis 67
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 67
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 66
Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration 66
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 66
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 65
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 65
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 63
In vivo effect of Mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients 63
Totale 10.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.785
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020324 0 0 0 0 0 0 0 0 0 0 212 112
2020/20211.105 33 100 27 95 120 65 101 45 118 92 280 29
2021/20221.616 135 100 33 197 50 59 46 250 97 84 245 320
2022/20233.242 383 432 266 466 226 431 149 276 390 49 123 51
2023/20241.648 62 466 60 120 53 224 115 70 24 57 181 216
2024/20253.213 79 99 308 144 205 206 249 242 629 291 761 0
Totale 14.862